Dexcom Q1 revenue $1.19B (+15% YoY), EPS $0.51; raises margin guidance

DEXCOM INC

2026-Q1 EPS reported $0.51 revenue$1,191,900,000

Q1 revenue $1.192B (+15% YoY); GAAP diluted EPS $0.51, non-GAAP $0.56.
US revenue +11%, international +26% reported (+17% organic) YoY.
GAAP operating margin 21.4% (+850 bps); non-GAAP 22.2% (+840 bps).
FY2026 guidance: revenue $5.16-5.25B; non-GAAP op margin raised to 23-23.5%.
Cash and marketable securities $2.42B; revolver undrawn.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

DEXCOM INC reported quarter ended March 31, 2026 results: revenue $1.192 billion, net income $199.5 million, EPS $0.51.

Period: quarter ended March 31, 2026
Revenue: $1.192 billion
Net income: $199.5 million
EPS: $0.51
Result: reported results

Exact text from the filing

(Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2026. First Quarter 2026 Financial Highlights: • Revenue grew 15% year-over-year to $1.192 billion on a reported basis and 12% year-over-year on an organic 1 basis. • U.S. revenue grew 11% and international revenue grew 26% on a reported basis and 17% on an organic 1 basis,

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.97

DEXCOM INC reported fiscal year 2026 results: revenue $5.16 - $5.25 billion. Guidance raised.

Period: fiscal year 2026
Revenue: $5.16 - $5.25 billion
Guidance: raised
Result: guidance update

Exact text from the filing

Dexcom is raising fiscal year 2026 guidance for Non-GAAP Operating Margin and Adjusted EBITDA Margin, and reiterating guidance for Revenue and Non-GAAP Gross Profit Margin at the following levels: • Revenue of $5.16 - $5.25 billion (approximately 11-13% growth) • Non-GAAP Gross Profit Margin of approximately 63-64% • Non-GAAP Operating Margin of approximately 23-23.5% • Adjusted EBITDA Margin of approximately 31-31.5%

View on SEC.gov

1427 earnings releases filed in the last 30 days. Browse all earnings releases →

DEXCOM INC filing history →

Source: SEC EDGAR

accession 0001093557-26-000072

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.